Vanguard Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Vanguard Capital Management's IART Position: Q3 2026 in Review
Vanguard Capital Management reduced its Integra LifeSciences (IART) stake by 0.74% in Q3 2026, selling an estimated $378K and leaving 2,924,264 shares worth $47.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.
Vanguard Capital Management first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $52.9M in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Vanguard Capital Management held 2,924,264 shares of Integra LifeSciences worth $47.6M as of Q3 2026.
- Vanguard Capital Management sold 21,909 Integra LifeSciences shares in Q3 2026, an estimated $378K.
- Integra LifeSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1913 holding.
- Vanguard Capital Management first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Integra LifeSciences position peaked at $52.9M in Q2 2026.
- 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.